Literature DB >> 30325986

Association of Androgen Deprivation Therapy With Dementia in Men With Prostate Cancer Who Receive Definitive Radiation Therapy.

Rishi Deka1,2,3, Daniel R Simpson1,2,3, Alex K Bryant1,2, Vinit Nalawade1,2,3, Rana McKay1,2, J D Murphy1,2,3, Brent S Rose1,2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30325986      PMCID： PMC6248075          DOI： 10.1001/jamaoncol.2018.4423

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  5 in total

1.  Discerning the survival advantage among patients with prostate cancer who undergo radical prostatectomy or radiotherapy: The limitations of cancer registry data.

Authors:  Stephen B Williams; Jinhai Huo; Karim Chamie; Marc C Smaldone; Christopher D Kosarek; Justin E Fang; Leslie A Ynalvez; Simon P Kim; Karen E Hoffman; Sharon H Giordano; Brian F Chapin
Journal:  Cancer       Date:  2017-01-18       Impact factor: 6.860

2.  Risk of Alzheimer's Disease Among Senior Medicare Beneficiaries Treated With Androgen Deprivation Therapy for Prostate Cancer.

Authors:  Seo Hyon Baik; Fabricio Sampaio Peres Kury; Clement Joseph McDonald
Journal:  J Clin Oncol       Date:  2017-08-25       Impact factor: 44.544

3.  Androgen Deprivation Therapy and the Risk of Dementia in Patients With Prostate Cancer.

Authors:  Farzin Khosrow-Khavar; Soham Rej; Hui Yin; Armen Aprikian; Laurent Azoulay
Journal:  J Clin Oncol       Date:  2016-11-21       Impact factor: 44.544

4.  Androgen Deprivation Therapy and Future Alzheimer's Disease Risk.

Authors:  Kevin T Nead; Greg Gaskin; Cariad Chester; Samuel Swisher-McClure; Joel T Dudley; Nicholas J Leeper; Nigam H Shah
Journal:  J Clin Oncol       Date:  2015-12-07       Impact factor: 44.544

5.  Association Between Androgen Deprivation Therapy and Risk of Dementia.

Authors:  Kevin T Nead; Greg Gaskin; Cariad Chester; Samuel Swisher-McClure; Nicholas J Leeper; Nigam H Shah
Journal:  JAMA Oncol       Date:  2017-01-01       Impact factor: 31.777
  5 in total
  6 in total

Review 1.  Cognitive functioning in thyroid cancer survivors: a systematic review and meta-analysis.

Authors:  Omar Saeed; Lori J Bernstein; Rouhi Fazelzad; Mary Samuels; Lynn A Burmeister; Lehana Thabane; Shereen Ezzat; David P Goldstein; Jennifer Jones; Anna M Sawka
Journal:  J Cancer Surviv       Date:  2019-04-04       Impact factor: 4.442

2.  Androgen Deprivation Therapy in Patients with Prostate Cancer is Associated with the Risk of Subsequent Alzheimer's Disease but Not with Vascular Dementia.

Authors:  Jong Won Kim; Do Kyung Kim; Hye Sun Lee; Ju-Young Park; Hyun Kyu Ahn; Jee Soo Ha; Dongu Lee; Kang Su Cho
Journal:  World J Mens Health       Date:  2021-06-29       Impact factor: 6.494

3.  Androgen-targeting therapeutics mitigate the adverse effect of GnRH agonist on the risk of neurodegenerative disease in men treated for prostate cancer.

Authors:  Gregory L Branigan; Georgina Torrandell-Haro; Maira Soto; Edward P Gelmann; Francesca Vitali; Kathleen E Rodgers; Roberta Diaz Brinton
Journal:  Cancer Med       Date:  2022-03-16       Impact factor: 4.711

4.  Androgen deprivation therapy for prostate cancer and risk of dementia.

Authors:  David Robinson; Hans Garmo; Mieke Van Hemelrijck; Jan-Erik Damber; Ola Bratt; Lars Holmberg; Lars-Olof Wahlund; Pär Stattin; Jan Adolfsson
Journal:  BJU Int       Date:  2019-02-06       Impact factor: 5.588

Review 5.  Impact of Testosterone on Alzheimer's Disease.

Authors:  Vittorio Emanuele Bianchi
Journal:  World J Mens Health       Date:  2022-01-02       Impact factor: 5.400

6.  Type of Androgen Deprivation Therapy and Risk of Dementia Among Patients With Prostate Cancer in Taiwan.

Authors:  Wen-Kuan Huang; Chi-Hung Liu; See-Tong Pang; Jia-Rou Liu; John Wen-Cheng Chang; Chuang-Chi Liaw; Cheng-Lung Hsu; Yung-Chang Lin; Lai-Chu See
Journal:  JAMA Netw Open       Date:  2020-08-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.